Risk of ticagrelor versus clopidogrel discontinuation. Response
Rev Esp Cardiol (Engl Ed). 2024 Apr;77(4):356-357.
doi: 10.1016/j.rec.2023.11.015.
Epub 2024 Jan 12.
[Article in
English,
Spanish]
Affiliations
- 1 Unidad de Agudos Cardiovascular, Hospital Universitario Virgen Macarena, Seville, Spain. Electronic address: trocor@gmail.com.
- 2 Unidad de Agudos Cardiovascular, Hospital Universitario Virgen Macarena, Seville, Spain.
No abstract available
MeSH terms
-
Acute Coronary Syndrome* / drug therapy
-
Clopidogrel / therapeutic use
-
Humans
-
Percutaneous Coronary Intervention*
-
Platelet Aggregation Inhibitors / therapeutic use
-
Ticagrelor / therapeutic use
-
Ticlopidine / therapeutic use
-
Treatment Outcome
Substances
-
Ticagrelor
-
Clopidogrel
-
Platelet Aggregation Inhibitors
-
Ticlopidine